MORNINGSIDE PHARMACEUTICALS LIMITED
Company Information
- Company Number
- 02672877
- Registered Address
- Nene House, 4 Rushmills, Northampton, England, NN4 7YB
- Status
- Active
- Employee Count
- 103
- Turnover
- £82,099,000
- EBITDA
- £14,225,000
Additional Details
- Company Type
- Private limited Company
- Incorporated On
- 18 December 1991
- Nature of Business
- 21200 - Manufacture of pharmaceutical preparations32500 - Manufacture of medical and dental instruments and supplies46460 - Wholesale of pharmaceutical goods
- Industries
- Life Sciences And Medical Technology,Supply Chain,Manufacturing And Commerce Models
- Region
- East Midlands
Time to Pay
Payment Timeline
Payment Features
Payment Score History
Performance Reports History
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Jan 2021 - 30 Jun 2021 | 30 Jul 2021 | 37 | 44% | 45% | 11% | 53% |
| 01 Jul 2020 - 31 Dec 2020 | 29 Jan 2021 | 35 | 51% | 42% | 7% | 19% |
| 01 Jan 2020 - 30 Jun 2020 | 27 Jul 2020 | 34 | 49% | 46% | 5% | 13% |
| 01 Jan 2019 - 30 Jun 2019 | 26 Jul 2019 | 50 | 49% | 37% | 14% | 34% |
| 01 Jul 2018 - 31 Dec 2018 | 29 Jan 2019 | 59 | 37% | 43% | 20% | 55% |
| 01 Jan 2018 - 30 Jun 2018 | 30 Jul 2018 | 46 | 25% | 54% | 21% | 72% |
Payment Time Trends
Payment Distribution Trends
Invoice Payment Practices
This information is as reported by the business, and responses are in their own words.
Payment Terms
Standard payment terms
Standard payment terms with UK suppliers are 30 days from month end. With foreign suppliers, payment terms range from the aboveto 90 days which can be from invoice date or shipment date.
Were there any changes to the standard payment terms in the reporting period?
No information available
Any other information about payment terms
All of the submitted figures do not take into account invoices that been put in query.
Maximum contractual payment period agreed
90
Dispute Resolution Process
We aim to resolve queries within payment periods where possible. This is done by the finance team alongside the budget holder.
Other Payment Information
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
Company Summary
Morningside Pharmaceuticals Limited is a UK-based pharmaceutical company that specializes in the development, manufacture, and distribution of high-quality generic medicines. The company was established in 1991 and has since grown to become a leading supplier of pharmaceutical products to over 100 countries worldwide.
The company's sustainability program is a key aspect of their operations, with a strong focus on ethical and responsible business practices. Morningside Pharmaceuticals is committed to reducing their environmental impact through efficient use of resources, waste reduction, and responsible disposal. They also prioritize the well-being and development of their employees, promoting diversity and inclusion in the workplace.
Morningside Pharmaceuticals offers a wide range of generic medicines, including injectables, tablets, capsules, and oral liquids. Their products cover a variety of therapeutic areas, such as cardiovascular, oncology, respiratory, and pain management. The company holds multiple accreditations and certifications, including ISO 9001, ISO 13485, and MHRA (Medicines and Healthcare products Regulatory Agency) licenses.
The key people at Morningside Pharmaceuticals include Dr. Nik Kotecha OBE, the Chairman and CEO, who founded the company, and Dr. Monika Juneja, the Managing Director, who oversees the day-to-day operations. Both have extensive experience in the pharmaceutical industry and are committed to the company's mission of improving global healthcare.
For more information on Morningside Pharmaceuticals, their products, and services, you can visit their website at www.morningsidepharm.com. Their registered office address is Morningside House, Unit C, 103 Nottingham Road, Loughborough, Leicestershire, LE11 1EJ, UK.
